The Trump Administration issued final rules (initially proposed in 2018 and 2019) aimed at lowering Medicare drug costs and reducing regulatory burdens in the Medicare program.
April 18, 2019 Joel Wood, SVP, Government Affairs and Joel Kopperud, VP, Government Affairs, give us the lowdown on AHPs, the ACA, Medicare for All and drug pricing—and what we can
December 5, 2018 It’s no secret that a government-controlled healthcare system would be disruptive—not only to the 156 million Americans with employer-sponsored healthcare, but also to those whom would be
November 8, 2018 The CMS proposed that drug manufacturers be required to disclose the list prices of drugs covered by Medicare or Medicaid in TV ads. In particular, manufacturers would
November 8, 2018 CMS released an advanced notice of proposed rulemaking—with the spring of 2019 targeted for a proposed rule—describing changes to the way Medicare pays for some drugs administered